Notice Information
Notice Title
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin
Notice Description
National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Lot Information
Lot No: 1-9
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points.
Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)This modification notice is to provide notice of the modification of the framework agreement (as defined below) to (i) extend its duration with a limited number of suppliers and (ii) increase the estimated value of the framework agreement across all lots.
The modification is further described in sections VII.2.1 and VII.2.2 below, but in short NHS England were required to (i) modify the Current Framework with the Absent Suppliers (as defined below) so as to extend the Current Framework for those Absent Products (as defined below) for a further period of (i) 3-months for IVIg products (Lots 1, 2, 5 and 6) (so to 30th September 2025) and (ii) 6-months for SCIg products (Lots 3 and 7) (so to 31st December 2025) and (ii) increase the estimated value of the Current Framework from PS1.2bn to PS1.6bn (an increase of 33%).
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)10% Intravenous Immunoglobulin (10% IVIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 3: Subcutaneous Immunoglobulin (SCIg)Subcutaneous Immunoglobulin (SCIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 4: Facilitated Subcutaneous Immunoglobulin (fSCIg)Facilitated Subcutaneous Immunoglobulin (fSCIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)10% Intravenous Immunoglobulin (10% IVIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)5: 5% Intravenous Immunoglobulin (5% IVIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 7: Subcutaneous Immunoglobulin (SCIg)Subcutaneous Immunoglobulin (SCIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 9: Anti-D Immunoglobulin (Anti-D)Anti-D Immunoglobulin (Anti-D)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Lot 8: Facilitated Subcutaneous Immunoglobulin (fSCIg)Facilitated Subcutaneous Immunoglobulin (fSCIg)
Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-028c7b
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/040406-2024
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651520 - Immunoglobulins
Notice Value(s)
- Tender Value
- £1,200,000,000 £1B-£10B
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,600,000,001 £1B-£10B
Notice Dates
- Publication Date
- 16 Dec 20241 years ago
- Submission Deadline
- 26 Feb 2021Expired
- Future Notice Date
- Not specified
- Award Date
- 23 Jun 20215 years ago
- Contract Period
- 1 Jul 2021 - 31 Mar 2025 3-4 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Active, Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS England
- Additional Buyers
The NHS Commissioning Board (operating under the name of NHS England)
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 8UG
- Postcode Area
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI45 Lambeth
- Delivery Location
- Not specified
-
- Local Authority
- Lambeth
- Electoral Ward
- Waterloo & South Bank
- Westminster Constituency
- Vauxhall and Camberwell Green
Further Information
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.